首页> 外国专利> Monoclonal Antibodies to Human MDRI Multiple Drug Resistant Gene Products, and Methods of Use Thereof (A MONOCLONAL ANTIBODY TO A HUMAN MDRI MULTIDRUG RESISTANCE GENE PRODUCT, AND USES)

Monoclonal Antibodies to Human MDRI Multiple Drug Resistant Gene Products, and Methods of Use Thereof (A MONOCLONAL ANTIBODY TO A HUMAN MDRI MULTIDRUG RESISTANCE GENE PRODUCT, AND USES)

机译:人类MDRI多药抗性基因产物的单克隆抗体及其使用方法(人类MDRI多药耐药基因产物的单克隆抗体及其用途)

摘要

(UIC2 mAb) specific for the extracellular domain of cell surface P-glycoprotein antigen associated with multidrug resistance in primate cells (UIC2 hybridoma, ATCC Approval No. HB11207), which produces a monoclonal antibody And a UIC2 / A hybridoma with ATCC approval number HB11287)mdr1 /RTI DNA-transformed spleen cells derived from Balb / c mice immunized with winter 3T3 fibroblasts. The resulting UIC2 mAb and its fragments and recombinant derivatives can then be used for the detection and isolation of multiple drug resistant primate cells and human mdr1 gene products and for the reversal of multiple drug resistance of primate cells, including multiple drug human tumor cells.
机译:(UIC2 mAb)特异于与灵长类细胞中多药耐药性相关的细胞表面P-糖蛋白抗原的细胞外结构域(UIC2杂交瘤,ATCC批准号HB11207),可产生单克隆抗体和UIC2 / A杂交瘤,ATCC批准号HB11287来自冬季3T3成纤维细胞免疫的Balb / c小鼠的uddr-1 DNA转化的脾细胞。然后,所得的UIC2 mAb及其片段和重组衍生物可用于检测和分离多种抗药性灵长类细胞和人类mdr1基因产物,以及用于逆转灵长类细胞(包括多种抗药性人类肿瘤细胞)的多种抗药性。

著录项

  • 公开/公告号KR1019957000938A

    专利类型

  • 公开/公告日1995-02-20

    原文格式PDF

  • 申请/专利权人 질에이 타르지안;

    申请/专利号KR1019940703296

  • 申请日1994-09-16

  • 分类号C07K15/28;C12N5/12;A61K39/395;

  • 国家 KR

  • 入库时间 2022-08-22 04:12:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号